Autarkic drug discovery in Japanese pharmaceutical companies: insights into national differences in industrial innovation
- 31 December 2003
- journal article
- Published by Elsevier BV in Research Policy
- Vol. 32 (10), 1805-1827
- https://doi.org/10.1016/s0048-7333(03)00062-3
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Organizational Learning in Multinationals: R&D Networks of Japanese and US MNEs in the UK*Journal of Management Studies, 2003
- Innovation as co-evolution of scientific and technological networks: exploring tissue engineeringResearch Policy, 2002
- Intellectual property rights and university-industry technology transfer in JapanScience and Public Policy, 1999
- Internationalization of corporate R&D: a study of Japanese and Swedish corporationsResearch Policy, 1999
- Foreign direct investment in industrial research in the pharmaceutical and electronics industries—results from a survey of multinational firmsResearch Policy, 1999
- How R&D is coordinated in Japanese and European multinationalsR&D Management, 1999
- Uncertainty, Trust, and Commitment Formation in the United States and JapanAmerican Journal of Sociology, 1998
- Pharmaceutical Firms and the Transition to Biotechnology: A Study in Strategic InnovationBusiness History Review, 1998
- Present at the biotechnological revolution: transformation of technological identity for a large incumbent pharmaceutical firmResearch Policy, 1997
- The globalization of R&D: Results of a survey of foreign-affiliated R&D laboratories in the USAResearch Policy, 1997